Home / Inspections / 1274952

FDA Inspection 1274952 — Novo Nordisk Pharmaceutical Industries LP

Novo Nordisk Pharmaceutical Industries LP — FEI 3016799712

The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries LP on July 30, 2025 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 30, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Durham, NC (United States)

Facility

Other inspections at this facility

  • 1233201 (NAI Wed Dec 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079946 (NAI Thu Dec 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1010958 (NAI Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources